Although the leading treatment for hemophilia is a replacement therapy in the form of both plasma-derived and rF products, research is underway for the discovery of novel agents.
Amy J. Guisinger, PharmD/MPH Candidate
Advertisement
Articles by Amy J. Guisinger, PharmD/MPH Candidate
Advertisement
Latest Updated Articles
Emerging Therapies for Hemophilia A and BPublished: January 22nd 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
GLP-1 Receptor Agonists Show Promise Across Alcohol, Opioid, and Tobacco Use Disorders
2
UConn’s Medical Writing Certificate Program: It’s Just "Write"
3
Pharmacy Policy Updates for October 2025
4
OpEd: The Drug Enforcement Administration Needs a Chief Pharmacy Officer. Here’s Why
5
